Drug Discovery - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

news

Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

· Optibrium, IFF and Intellegens’ joint peer-reviewed research published in Journal of Computer Aided Molecular Design · Study demonstrates accuracy a...

10 December 2021 news AI | artificial intelligence

Continue Reading →

Volume 4 Issue 4

Benefits & Key Considerations of Using Human iPSC-Derived Disease Models in Drug Discovery

The process of drug discovery, development and commercialisation is long and associated with high costs. In addition, it is estimated that only 1% of the initially te...

9 December 2021 Volume 4 Issue 4 Disease Models | Drug Discovery

Continue Reading →

news

Optibrium Releases 3D Ligand-based Design Module for StarDrop Drug Discovery Software

Optibrium Ltd, a developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for sma...

9 September 2021 news Drug Discovery | Drug Discovery Software

Continue Reading →

Volume 4 Issue 3

CRISPR-Cas9 Knockout Screening Using Primary Human Cells in Drug Discovery

While significant progress has been made carrying out CRISPR screens in immortalised cell lines, a more physiological and clinically relevant alternative is human pri...